Less Ads, More Data, More Tools Register for FREE

Pin to quick picksImperial Innovations Group Share News (IVO)

  • There is currently no data for IVO

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Imperial Innovations Profit Up As Portfolio Boosted By Circassia IPO

Wed, 15th Oct 2014 10:05

LONDON (Alliance News) - Imperial Innovations Group PLC Wednesday posted a jump in pretax profit for the year to end-July as the value of its portfolio rose, boosted by the listing of its largest investment Circassia Pharmaceuticals PLC.

The intellectual property company posted a pretax profit of GBP27.4 million, multiplying from GBP3.8 million a year before, boosted by a GBP40.5 million fair value gain on investment as the company's net portfolio value rose 38%, mostly on the back of the successful initial public offering of Circassia.

The company's net portfolio value rose to GBP252.0 million from GBP182.6 million a year before.

Circassia raised GBP200.0 million in its IPO, which Imperial Innovations said is "widely believed to be the biggest ever biotech fundraising at IPO in the UK market".

Three other companies in its portfolio also listed during its recent financial year, with Abzena PLC listing on AIM in July, Ixico PLC listing on AIM last October, and Oxford Immunotec Ltd listing on the NASDAQ in November last year.

Imperial Innovations posted revenues of GBP3.6 million in the financial year, compared to GBP3.3 million a year before.

The company added 13 new companies to its portfolio during the year. It reviewed 402 invention disclosures, compared to 386 a year before, and signed 27 commercial agreements.

It filed 57 patents during the year, compared to 43 a year before.

Imperial Innovations raised GBP150 million during the year, and the company said following this fundraising and given the "increasing maturity" of its portfolio, it will begin to deploy more capital into its investment portfolio. It does "not envisage a significant increase in the number of new companies invested in."

"We have the capital, proven operational and managerial expertise, as well as access to the intellectual property from the academic and research community in the 'Golden Triangle' - home to the UK's four leading research-intensive Universities," said Chairman Martin Knight in a statement. "This all bodes well for the future and further value creation."

Shares in Imperial Innovations are trading up 5.4% at 470.00 pence Wednesday morning.

By Hana Stewart-Smith; hanassmith@alliancenews.com; @HanaSSAllNews

Copyright 2014 Alliance News Limited. All Rights Reserved.

More News
24 Sep 2021 11:10

AIM WINNERS & LOSERS: In The Style shares shredded by profit warning

AIM WINNERS & LOSERS: In The Style shares shredded by profit warning

Read more
5 Jan 2017 16:45

Imperial Innovations completes quick-change to Touchstone

(ShareCast News) - Imperial Innovations Group announced on Thursday that, further to the shareholder approval received at its AGM on 21 November 2016, the change of the company's name to Touchstone Innovations took effect on 4 January. The AIM-traded firm added that, with effect from 0800 GMT on Thu

Read more
28 Oct 2016 14:18

Imperial Innovations to change name to 'Touchstone'

(ShareCast News) - Imperial Innovations Group announced on Friday that at its annual general meeting on 21 November, it will be seeking shareholder approval to change the name of the company to Touchstone Innovations. The AIM-traded group was originally formed as the technology transfer office for I

Read more
24 Oct 2016 15:04

Imperial Innovations celebrates investment momentum

(ShareCast News) - Imperial Innovations Group noted on Monday that its portfolio company, Veryan Medical, has completed enrolment into the MIMICS-2 clinical study of its BioMimics 3D Self-Expanding Stent System. The AIM-traded firm said the MIMICS-2 study is a prospective, multicentre, interventiona

Read more
24 Oct 2016 06:59

Imperial Innovations Says Veryan Completes Clinical Study Enrolment

Read more
13 Oct 2016 08:36

Imperial Innovations' increases investments as pre-tax loss widens

(ShareCast News) - Imperial Innovations' annual pre-tax loss widened while the technology commercialisation and investment company increased investments across its business with universities and a joint venture. For the year ended 31 July, the pre-tax loss widened to £63.1m from £15.1m, last year, w

Read more
6 Oct 2016 15:15

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more
6 Oct 2016 15:15

Imperial Innovations shares up on portfolio company progress

(ShareCast News) - Imperial Innovations Group updated the market on Thursday, noting that its portfolio company TopiVert Pharma has announced that the first patients have been dosed in its Phase IIa proof-of-concept study to evaluate the safety, tolerability and efficacy of a rectal formulation of T

Read more
6 Oct 2016 06:31

Imperial Innovations: Topivert Moves To Phase Two Of TOP1288 Study

Read more
3 Oct 2016 15:20

Imperial Innovations sells Permasense portfolio business

(ShareCast News) - AIM-listed Imperial Innovations has sold its portfolio company Permasense to Fortune 500 company Emerson Electric for an initial consideration of £30.6m in cash. Further amounts of up to £10m may be paid in addition, subject to the Permasense business achieving certain performance

Read more
21 Sep 2016 12:23

Imperial Innovations invests £5.1m in new biotech start-up

(ShareCast News) - AIM-listed technology investor Imperial Innovations invested £5.1m in Artios Pharma, a new biotech start-up launched on Wednesday. Imperial Innovations contributed £5.1m to the £25m series A funding round, giving it a 14.9% interest in the new Cambridge- based company. Artios, wh

Read more
19 Aug 2016 09:23

Cambridge University innovation investor raises 75 million pounds

LONDON, Aug 19 (Reuters) - Cambridge Innovation Capital, which commercializes technology and healthcare research from Cambridge University, has raised 75 million pounds ($98 million) from investors, including for the first time Woodford Investment Management. CIC, founded in 2013, has alrea

Read more
12 Jul 2016 06:55

Imperial Innovations Notes Cell Medica Acquisition Of Delenex

Read more
6 Jul 2016 06:41

Imperial Innovations Takes Part In New Funding For Econic Technologies

Read more
30 Jun 2016 11:39

Imperial Innovations Says PsiOxus Signs Deal With Bristol-Myers Squibb

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.